Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Cvirn

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Nutrients|September 9, 2023
Polyphenols' Impact on Selected Biomarkers of Brain Aging in Healthy Middle-Aged and Elderly Subjects: A Review of Clinical TrialsTobias Ziegler, Melina Tsiountsioura, Lisa Meixner-Goetz, et al.
Pediatrics|August 3, 2007
Myocardial infarction in an adolescent: anomalous origin of the left main coronary artery from the right coronary sinus in association with combined prothrombotic defectsMartin Koestenberger, Bert Nagel, Andreas Gamillscheg, et al.
International Journal of Molecular Sciences|December 23, 2022
Redox State of Human Serum Albumin in Multiple Sclerosis: A Pilot StudyMargret Paar, Katharina Seifried, Gerhard Cvirn, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2006
Effects of melagatran on activated partial thromboplastin time and on ecarin clotting time in cord versus adult plasmaMartin Koestenberger, Siegfried Gallistl, Leschnik Bettina, et al.
Thrombosis and Haemostasis|August 23, 2005
Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasmaMartin Koestenberger, Siegfried Gallistl, Wolfgang Muntean, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 5, 2005
An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastographyMartin Koestenberger, Siegfried Gallistl, Wolfgang Muntean, et al.
Thrombosis Research|June 14, 2002
Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasmaGerhard Cvirn, Siegfried Gallistl, Martin Koestenberger, et al.
Journal of Clinical Medicine|September 30, 2020
Menstrual Phase Affects Coagulation and Hematological Parameters during Central HypovolemiaNandu Goswami, Bianca Brix, Andreas Roessler, et al.
Journal of Thrombosis and Thrombolysis|March 4, 2005
Drotrecogin alfa (activated, Xigris) in combination with heparin or melagatran: an in vitro investigationMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Thrombosis Research|November 30, 2004
Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examinationMartin Koestenberger, Siegfried Gallistl, Gerhard Cvirn, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Nutrients|September 9, 2023
Polyphenols' Impact on Selected Biomarkers of Brain Aging in Healthy Middle-Aged and Elderly Subjects: A Review of Clinical TrialsTobias Ziegler, Melina Tsiountsioura, Lisa Meixner-Goetz, et al.
Pediatrics|August 3, 2007
Myocardial infarction in an adolescent: anomalous origin of the left main coronary artery from the right coronary sinus in association with combined prothrombotic defectsMartin Koestenberger, Bert Nagel, Andreas Gamillscheg, et al.
International Journal of Molecular Sciences|December 23, 2022
Redox State of Human Serum Albumin in Multiple Sclerosis: A Pilot StudyMargret Paar, Katharina Seifried, Gerhard Cvirn, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 15, 2006
Effects of melagatran on activated partial thromboplastin time and on ecarin clotting time in cord versus adult plasmaMartin Koestenberger, Siegfried Gallistl, Leschnik Bettina, et al.
Thrombosis and Haemostasis|August 23, 2005
Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasmaMartin Koestenberger, Siegfried Gallistl, Wolfgang Muntean, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 5, 2005
An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastographyMartin Koestenberger, Siegfried Gallistl, Wolfgang Muntean, et al.
Thrombosis Research|June 14, 2002
Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasmaGerhard Cvirn, Siegfried Gallistl, Martin Koestenberger, et al.
Journal of Clinical Medicine|September 30, 2020
Menstrual Phase Affects Coagulation and Hematological Parameters during Central HypovolemiaNandu Goswami, Bianca Brix, Andreas Roessler, et al.
Journal of Thrombosis and Thrombolysis|March 4, 2005
Drotrecogin alfa (activated, Xigris) in combination with heparin or melagatran: an in vitro investigationMartin Koestenberger, Gerhard Cvirn, Siegfried Gallistl, et al.
Thrombosis Research|November 30, 2004
Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examinationMartin Koestenberger, Siegfried Gallistl, Gerhard Cvirn, et al.
Pageof 11